Lung Cancer Drug Approved In China

AstraZeneca said that China granted marketing authorization for its lung cancer pill Tagrisso, a drug with clinical name "Osimertinib" designed for the treatment of adult patients with certain genetic mutations. China has one of world's largest rates of lung cancer.

http://news.xinhuanet.com/english/2017-03/28/c_136162513.htm


bibi1581.blogspot.com

Comments

Popular posts from this blog

Your 1600 Update

Bibi1581 Blog For 9/13/2017: Morning Edition

Bibi1581 Blog For 9/12/2017:Evening Edition